Bayer’s strongest-ever pharma portfolio and promising pipeline drive future growth – Bangkok Post

Posted on by admin


  1. Bayer’s strongest-ever pharma portfolio and promising pipeline drive future growth  Bangkok Post
  2. Newly Published Phase 3 OCEANIC-STROKE Trial Data Show Asundexian Reduces Recurrent Ischemic Stroke Risk  NeurologyLive
  3. Bayer pushes beyond limits of treatment in stroke, heart failure, and prostate cancer  koreabiomed.com
  4. New anti-clotting medication lowers risk of stroke without added bleeding  Medical Xpress
  5. Bayers Asundexian Cuts Stroke Risk by 26% in Phase III Study  Voice of Healthcare

Related Posts

Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Clinical and Metabolic Outcomes in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Specialty Please chooseI’m not a medical professional.Allergy and ImmunologyAnatomyAnesthesiologyBiostatisticsCardiac/Thoracic/Vascular SurgeryCardiologyCritical CareDentistryDermatologyDiabetes and EndocrinologyEmergency MedicineEpidemiology and Public HealthFamily MedicineForensic MedicineGastroenterologyGeneral PracticeGeneticsGeriatricsHealth PolicyHematologyHIV/AIDSHospital-based MedicineI’m not a medical […]